Status:
ACTIVE_NOT_RECRUITING
Continuous Versus Bolus Administration of G-CSF in Children With Cancer
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Pediatric Cancer
Neutropenia
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE4
Brief Summary
The investigators hypothesized that in terms of granulocyte colony-stimulating factor (G-CSF) administration, the route of continuous infusion would lead to a faster neutrophil recovery compared to th...
Detailed Description
The investigators aimed to enroll 40 hospitalized patients in this phase 4 clinical trial. Patients with an ANC lower than 500 cells/mm3 will be randomly categorized into experimental and controlled a...
Eligibility Criteria
Inclusion
- Pediatric patients with an age between 0 to 18 years old will be included
- Hematologic and oncologic malignancies
Exclusion
- Patients with a diagnosis of myelodysplastic syndrome or severe aplastic anemia will be excluded
- Patients receiving G-CSF treatment 7 days before enrollment will be excluded
- Patients concurrently receiving cytokine therapy or thrombopoietin receptor agonist therapy will be excluded
Key Trial Info
Start Date :
November 23 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06145321
Start Date
November 23 2023
End Date
November 15 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Children Hospital
Taoyuan District, ROC, Taiwan, 333005